CHP Beauregard
About CHP Beauregard
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CHP Beauregard
During the past decade, CHP Beauregard conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
2014-01-24
2025-03-20
Recruiting
146
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
2013-12-23
2023-07-01
Active, not recruiting
488
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CHP Beauregard" #1 sponsor was "LivaNova" with 3 trials, followed by "Biosensors Europe SA" with 1 trials
sponsored, "European Cardiovascular Research Center" with 1 trials sponsored, "French Cardiology Society" with 1 trials sponsored and "Hexacath, France"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at CHP Beauregard
According to Clinical.Site data, the most researched conditions in "CHP Beauregard" are
"Acute Coronary Syndrome" (1 trials), "Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients." (1 trials), "Atrial Fibrillation, Persistent" (1 trials), "Biventricular Tachycardias" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "CHP Beauregard" in a lesser frequency.
Clinical Trials Intervention Types at CHP Beauregard
Most popular intervention types in "CHP Beauregard" are "Device" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ablation by radiofrequency of low-voltage areas" (1 trials), "Angioplasty (PROMUS Element™, and Xience™ Prime stent)" (1 trials), "Cardiac Resynchronization Therapy -Defibrillator (range PARADYM, LivaNova, Clamart, France)" (1 trials), "Cobalt-Chromium Bare Metal Stents" (1 trials) and "Isolation of pulmonary veins" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHP Beauregard
The vast majority of trials in "CHP Beauregard" are
8 trials for "All" genders.
Clinical Trials Status at CHP Beauregard
Currently, there are NaN active trials in "CHP Beauregard".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in CHP Beauregard,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHP Beauregard, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 1 trials that are defined as “Not Applicable".